drugset / Trial / NCT04615962
Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.
RandomizedSingle-groupTriple-blindTreatment
Summary
The investigators aimed to understand better the efficacy in a randomized, double-blind, intraindividual design trial in 66 participants with AD treated with SNG100, and 2 different strengths of topical steroids hydrocortisone and the medium potent mometasone furoate cream.
Timeline
- Start
- 2021-01-01
- Primary completion
- 2022-01
- Completion
- 2022-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrocortisone | Other / unclassified | 1 % | Topical |
| Comparator | Mometasone | Other / unclassified | — | — |
| Subject | SNG100 | Other / unclassified | — | Topical |